Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-27T14:54:29.876Z Has data issue: false hasContentIssue false
  • English
  • Français

Pregnancy and bipolar disorder: the risk of recurrence when discontinuing treatment with mood stabilisers: a systematic review

Published online by Cambridge University Press:  17 November 2016

Erik Roj Larsen  and
Kristina Saric
Erik Roj Larsen*
Affiliation:
Department of Affective Disorders Q, Mood Disorders Research Unit, Aarhus University Hospital, Risskov, Denmark
Kristina Saric
Affiliation:
Department of Affective Disorders Q, Mood Disorders Research Unit, Aarhus University Hospital, Risskov, Denmark
*
Erik Roj Larsen, Department of Affective Disorders Q, Mood Disorders Research Unit, Aarhus University Hospital, DK-8240 Risskov, Denmark. Tel: +45 78 47 21 30; Fax: +45 78472129 E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

Bipolar disorder in pregnancy may be difficult to treat. The dilemma is whether the women should continue medication throughout pregnancy, and maybe accept a minor risk to harm their unborn child, or discontinue medication and increase the risk of recurrence, which can lead to maternal morbidity, thereby endangering themselves and their foetus.

Design and methods

In September 2016, three electronic search databases; PubMed, Scopus and PsycInfo, were used searching for clinical trials concerning this question. Eight clinical trials concerning risk of recurrence after discontinuation of medication in pregnancy were included.

Results

There is no consensus concerning the risk of discontinuation of medication during pregnancy among bipolar women. The evidence from the trials included underscore that there seem to be a group of pregnant women who are stable despite they are not receiving mood stabilisers during pregnancy. Besides, there is a group of more severe and more unstable bipolar disorders that seem to benefit of a more close monitoring, support and prophylactic medication during pregnancy and postpartum period to prevent recurrence.

Conclusion

For the more stable bipolar women we recommend a well planned and more slowly discontinuation of medication before pregnancy. For the unplanned pregnancies it is important to consider the possibility of a more slowly discontinuation. For the more severe conditions of bipolar disorder, it is important to secure a close monitoring of medication. As the risk of postpartum relapse is high, medication may be started soon after delivery.

Keywords

bipolar disordermedicationmood disorderpregnancydiscontinuation
Type
Review Article
Information
Acta Neuropsychiatrica , Volume 29 , Issue 5 , October 2017 , pp. 259 - 266
Check for updates
Copyright
© Scandinavian College of Neuropsychopharmacology 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Merikangas, KR, Jin, R, He, JP, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011;68:241–251.Google Scholar
2. Morken, G, Vaaler, AE, Folden, GE, Andreassen, OA, Malt, UF. Age at onset of first episode and time to treatment in in-patients with bipolar disorder. Br J Psychiatry 2009;194:559–560.Google Scholar
3. Post, RM, Denicoff, KD, Leverich, GS, et al. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry 2003;64:680–690. quiz 738–739.Google Scholar
4. Magalhaes, PV, Kapczinski, F, Nierenberg, AA, et al. Illness burden and medical comorbidity in the systematic treatment enhancement program for bipolar disorder. Acta Psychiatr Scand 2012;125:303–308.Google Scholar
5. Freeman, MP, Smith, KW, Freeman, SA, et al. The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry 2002;63:284–287.Google Scholar
6. Maina, G, Rosso, G, Aguglia, A, Bogetto, F. Recurrence rates of bipolar disorder during the postpartum period: a study on 276 medication-free Italian women. Arch Womens Ment Health 2014;17:367–372.Google Scholar
7. Viguera, AC, Nonacs, R, Cohen, LS, Tondo, L, Murray, A, Baldessarini, RJ. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000;157:179–184.CrossRefGoogle ScholarPubMed
8. Grof, P, Robbins, W, Alda, M, et al. Protective effect of pregnancy in women with lithium-responsive bipolar disorder. J Affect Disord 2000;61:31–39.CrossRefGoogle ScholarPubMed
9. Di Florio, A, Forty, L, Gordon-Smith, K, et al. Perinatal episodes across the mood disorder spectrum. JAMA Psychiatry 2013;70:168–175.CrossRefGoogle ScholarPubMed
10. Viguera, AC, Tondo, L, Koukopoulos, AE, Reginaldi, D, Lepri, B, Baldessarini, RJ. Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatry 2011;168:1179–1185.Google Scholar
11. Galbally, M, Roberts, M, Buist, A. Mood stabilizers in pregnancy: a systematic review. Aust N Z J Psychiatry 2010;44:967–977.Google ScholarPubMed
12. Larsen, ER, Damkier, P, Pedersen, LH, et al. Use of psychotropic drugs during pregnancy and breast-feeding. Acta Psychiatr Scand Suppl 2015;445:1–28.CrossRefGoogle Scholar
13. Sharma, V, Pope, CJ. Pregnancy and bipolar disorder: a systematic review. J Clin Psychiatry 2012;73:1447–1455.Google Scholar
14. Henshaw, SK. Unintended pregnancy in the United States. Fam Plann Perspect 1998;30:24–9, 46.CrossRefGoogle ScholarPubMed
15. Newport, DJ, Stowe, ZN, Viguera, AC, et al. Lamotrigine in bipolar disorder: efficacy during pregnancy. Bipolar Disord 2008;10:432–436.Google Scholar
16. Rosso, G, Albert, U, Di Salvo, G, Scata, M, Todros, T, Maina, G. Lithium prophylaxis during pregnancy and the postpartum period in women with lithium-responsive bipolar I disorder. Arch Womens Ment Health 2016;19:429–432.CrossRefGoogle ScholarPubMed
17. Abdel-Hay, M, El-Sawy, H, Badawy, A. Predictors of recurrence of bipolar disorder during pregnancy and postpartum periods in a sample of Egyptian women. Middle East Curr Psychiatry 2011;18:45–50.CrossRefGoogle Scholar
18. Bergink, V, Bouvy, PF, Vervoort, JS, Koorengevel, KM, Steegers, EA, Kushner, SA. Prevention of postpartum psychosis and mania in women at high risk. Am J Psychiatry 2012;169:609–615.Google Scholar
19. Viguera, AC, Whitfield, T, Baldessarini, RJ, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007;164:1817–1824. quiz 1923.CrossRefGoogle ScholarPubMed
20. Sharma, V, Sommerdyk, C, Xie, B, Campbell, K. Pharmacotherapy of bipolar II disorder during and after pregnancy. Curr Drug Saf 2013;8:246–252.Google Scholar
21. Viguera, AC, Cohen, LJ, Tondo, L, Baldessarini, RJ. Protective effect of pregnancy on the course of lithium-responsive bipolar I disorder. J Affect Disord 2002;72:107–108. author reply 103–105.CrossRefGoogle ScholarPubMed
22. Burt, VK, Bernstein, C, Rosenstein, WS, Altshuler, LL. Bipolar disorder and pregnancy: maintaining psychiatric stability in the real world of obstetric and psychiatric complications. Am J Psychiatry 2010;167:892–897.Google Scholar
23. Yonkers, KA, Vigod, S, Ross, LE. Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women. Obstet Gynecol 2011;117:961–977.Google Scholar
24. Christensen, J, Gronborg, TK, Sorensen, MJ, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013;309:1696–1703.Google Scholar
25. Khan, SJ, Fersh, ME, Ernst, C, Klipstein, K, Albertini, ES, Lusskin, SI. Bipolar disorder in pregnancy and postpartum: principles of management. Curr Psychiatry Rep 2016;18:13.Google Scholar
26. Wald, MF, Muzyk, AJ, Clark, D. Bipolar depression: pregnancy, postpartum, and lactation. Psychiatr Clin North Am 2016;39:57–74.CrossRefGoogle ScholarPubMed
Supplementary material: File

Larsen and Saric supplementary material

Supplementary Table

Download Larsen and Saric supplementary material(File)
File 16.2 KB